|
|
|
|
|
|
|
J Neuropsychiatry Clin Neurosci 2010,Dec,21;22(1):48-54; (PMID: 20160209)
The authors examined the long-term cognitive implications of cancer treatment among breast cancer survivors over 65 years old who received treatment during midlife. Thirty women survivors were matched with 30 noncancer, healthy older adults in terms of age, education, and IQ.[...]
|
|
|
Ethn Dis 2010,Dec,21;20(1 Suppl 1):S1-60-4; (PMID: 20521387)
[...]INTRODUCTION: Endothelial dysfunction plays a critical role in the pathogenesis of cardiovascular diseases and cancer. Bone marrow-derived multipotent adult progenitor cells (MAPC) have the potential to differentiate, at the single cell level, toward the three embryonic [...]
|
|
|
Ethn Dis 2010,Dec,21;20(1 Suppl 1):S1-12-6; (PMID: 20521378)
INTRODUCTION: Cancer causes about 13% of all deaths. According to the American Cancer Society, world-wide cancer deaths were 7.6 million in 2007.[...]
|
|
|
Ethn Dis 2010,Dec,21;20(1 Suppl 1):S1-168-72; (PMID: 20521409) [FULL TEXT AVAILABLE]
[...] has been studied, but there is no data regarding Hispanics, which have a higher mortality rate from Prostate Cancer (PCa) than Whites. The objective of this study was to investigate if being [...] from 2003-2005 at the urology clinics of the Veterans Administration Caribbean Healthcare System. Accrued data included body mass index (BMI), age, PSA levels, biopsy results, and cancer status after treatment. RESULTS: In men, with normal age adjusted PSA levels, overweight and [...]
|
|
|
MEDICC Rev 2010,Dec,21;12(1):29-32; (PMID: 20387332)
INTRODUCTION: Despite advances in diagnostic techniques and treatment, lung cancer is the leading cause of cancer death worldwide and in Cuba. Prompt initiation of cancer therapy depends on rapid diagnostic confirmation;[...]
|
|
|
MEDICC Rev 2010,Dec,21;12(1):36-40; (PMID: 20387333)
Clinical management of breast cancer, making a prognosis and deciding on treatment, currently depend on defining prognostic factors, especially hormone receptors (HR).[...]
|
|
|
MEDICC Rev 2010,Dec,21;12(1):17-23; (PMID: 20387330)
[...]INTRODUCTION: CIMAvax EGF is a therapeutic anticancer vaccine developed entirely in Cuba and licensed in Cuba for use in adult patients with stage IIIB/IV non-small-cell lung cancer (NSCLC). The vaccine is based on active immunotherapy by which an individual's immune response[...]
|
|
|
Urol J 2010,Dec,21;7(1):26-9; (PMID: 20209452)
[...]INTRODUCTION: Recent scientific attention has focused on the role of growth factors in the progression of cancer. HER-2/neu is an epidermal growth factor receptor that is demonstrated to have correlation with poor prognosis of many [...]
|
|
|
Urol J 2010,Dec,21;7(1):1-9; (PMID: 20209445)
[...]MATERIALS AND METHODS: Evidence was collected by review of current literature, guidelines of the American and European associations and the national comprehensive cancer network. RESULTS: Treatment of advanced RCC has recently undergone a major change with the development of [...]
|
|
|
J Psychohist 2010,Dec,21;37(3):208-23; (PMID: 20481137)
|
 1 2 3 4 5 6 7 8 
|
|
|
|
|
